Advertisement

Topics

Latest "Indiana Blood Marrow Transplantation" News Stories

02:05 EST 18th December 2017 | BioPortfolio

Here are the most relevant search results for "Indiana Blood Marrow Transplantation" found in our extensive news archives from over 250 global news sources.

More Information about Indiana Blood Marrow Transplantation on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Indiana Blood Marrow Transplantation for you to read. Along with our medical data and news we also list Indiana Blood Marrow Transplantation Clinical Trials, which are updated daily. BioPortfolio also has a large database of Indiana Blood Marrow Transplantation Companies for you to search.

Showing "Indiana Blood Marrow Transplantation" News Articles 1–25 of 6,100+

Extremely Relevant

CHLA awarded $1.3 million by NIH for Pediatric Blood and Marrow Transplantation Consortium

(Children's Hospital Los Angeles) Michael Pulsipher, M.D., of Children's Hospital Los Angeles is awarded $1.3 million by the National Heart, Lung, and Blood Institute of the NIH. The funding represents a Clinical Trial Network Core Center Renewal for the Pediatric Blood and Marrow Transplantation Consortium and support for an innovative clinical trial that seeks to compare outcomes for young patie...


CytoDyn’s PRO 140 Monoclonal Antibody Prevents Graft-Versus-Host Disease in Model of Bone ...

PRO 140 Currently in Phase 2 Clinical Trial in Leukemia Patients Receiving Bone Marrow Transplants Preclinical Proof-of-Concept Published in Biology of Blood and Marrow Transplantation VANCOUVER, Washington, Nov. 14, 2017 (GLOBE NEWSWIRE) Read more...

Actinium Pharmaceuticals to Participate in American Society for Blood and Marrow Transplantation 2017 Corporate Council Meeting

- Actinium is now a member of the ASBMT™ Corporate Council - Two day event focused on facilitating dialogue aimed at advancing the field of bone marrow transplantation and cellular therapy NEW YORK, Sept. 20, 2017 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE American:ATNM) ("Actinium" or "the Company"), a biopharmaceutical company developing innovative targeted therapies for...


Stem Cell Subset Source of All Blood Cells, Basis of Bone Marrow Transplant Success

A new blood system isn’t created from scratch—just something close to it. A single type of stem cell, a new study demonstrates, can fully repopulate the bone marrow and give rise to all the cell lineages that constitute a complete blood system. This blood-forming stem cell is distinguished by three surface markers—or rather the presence of two markers and the absence of a third. By heedi...

Monoclonal antibody prevents graft-vs-host disease in bone marrow transplantation model

(Bioscribe) New research provides preclinical proof-of-concept for the ability of PRO 140, a humanized anti-CCR5 monoclonal antibody under development by CytoDyn Inc., to effectively block the development of graft-versus-host disease, a potentially lethal complication of bone marrow stem cell transplantation. CytoDyn is currently enrolling patients in a Phase 2 clinical trial with PRO 140 for the ...

Targeting bone marrow protein could be effective way to improve stem cell transplants

Bone marrow contains hematopoetic stem cells, the precursors to every blood cell type. These cells spring into action following bone marrow transplants, bone marrow injury and during systemic infection, creating new blood cells, including immune cells, in a process known as hematopoiesis.

Relevant

CRISPR Illuminates Pediatric Bone Marrow Failure Syndrome

Children with dyskeratosis congenita experience progressive bone marrow failure, eventually losing the ability to make red blood cells, white blood...

Weight loss surgery's effects on bone marrow fat and bone mass

Bone marrow fat is thought to regulate bone metabolism, and high levels of marrow fat are seen in states of low bone mass, severe underweight, and diabetes. In a study of obese women undergoing gastric bypass surgery, increases in bone marrow fat were associated with a greater decline in bone density. Furthermore, in diabetic women undergoing the surgery, improvements in blood sugar control were a...

Dutch Bone Marrow Transplant for Blood Cancer could get rid of Donor Matching

Kiadis Pharma starts Phase III trials with ATIR101, a therapy that could make half-matched donors suitable for bone marrow transplant to treat blood cancer.  From its Amsterdam headquarters, Kiadis Pharma is developing a technology that could solve one of the biggest ... This awesome article Dutch Bone Marrow Transplant for Blood Cancer could get rid of Donor Matching appeared first on Labiotech...

Immobilisation of Delta-like 1 ligand for the scalable and controlled manufacture of hematopoietic progenitor cells in a stirred bioreactor

Umbilical cord blood provides a source of hematopoietic stem cells for transplantation with immunological and availability advantages over conventional bone marrow sources. Limited cell numbers and slower engr...

Omeros Reports Additional and Consistently Positive Data for OMS721 in Patients with Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy

-- Preparing to Initiate Phase 3 Clinical Program -- SEATTLE, Oct. 26, 2017 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced further positive data from the company's ongoing Phase 2 study of OMS721 evaluating patients with hematopoietic stem cell transplant-associated thrombotic microangiopathy (HCT-TMA). Initial positive data from this study have been presented at the 2017 comb...

Novel harvesting method rapidly produces superior stem cells for transplantation

A new method of harvesting stem cells for bone marrow transplantation - developed by a team of investigators from the Massachusetts General Hospital (MGH) Cancer Center and the Harvard Stem Cell Institute - appears to accomplish two goals: making the...

U.S. FDA Approves IMBRUVICA® (ibrutinib) as First Approved Treatment Specifically for Adults ...

"Stem cell and bone marrow transplants can be life-saving treatment options for people with blood cancers or marrow failure syndromes; however, nearly half of transplant Read more...

Precision medicine opens the door to scientific wellness preventive approaches to suicide

(Indiana University) Researchers have developed a more precise way of diagnosing suicide risk, by developing blood tests that work in everybody, as well as more personalized blood tests for different subtypes of suicidality that they have newly identified, and for different psychiatric high-risk groups. The work, led by the Indiana University School of Medicine, is reported in the journal Molecula...

Dr. Yaser Homsi Joins The Oncology Institute of Hope and Innovation

The Oncology Institute of Hope Innovation welcomes Dr. Homsi to its team of specialists. Downey, CA (PRWEB) September 08, 2017 The Oncology Institute of Hope Innovation welcomes Dr. Homsi to its team of specialists. Dr. Yaser Homsi is a passionate and knowledgeable Hematologist that received his Medical education from the University of Aleppo in Aleppo, Syria. After graduation, Homsi moved to Ind...

Treatment for Rare Blood Cancer Gets FDA Okay

NewsErdheim-Chester Disease (ECD) is a slow-growing blood cancer that originates in the bone marrow. It causes an increased production of histiocytes, a type of white blood cell.

Leukemia May Shrivel If Fat Cells in Marrow Are Plumped

Bolstered by an adipogenesis-promoting drug, fat cells in the bone marrow effectively “crowded out” leukemia, yet they made room for healthy blood cells. Such effects are not simply due to physical crowding in the bone marrow niche. They are more about cells cramping each other’s styles while they try to attain their fully differentiated forms. Altering the bone marrow environment so tha...

Bone marrow models to study blood and musculoskeletal disorders

(Karlsruher Institut für Technologie (KIT) ) For her research on development of hematological and musculoskeletal disorders, Dr. Cornelia Lee-Thedieck, scientist at Karlsruhe Institute of Technology, is awarded an ERC Starting Grant: The European Research Council decided to fund her project 'bloodANDbone' with €1.5 million for five years. Lee-Thedieck develops models of the human bone marrow...

Treatment For Rare Blood Cancer Gets FDA OK

NewsErdheim-Chester Disease (ECD) is a slow-growing blood cancer that originates in the bone marrow.

It’s Blood Cancer Awareness Month: Spotlight on Lymphoma

Lymphoma and leukemia are both blood cancers, meaning that they involve cells of the blood or bone marrow. The American […] The post It’s Blood Cancer Awareness Month: Spotlight on Lymphoma appeared first on .

MCG, AU Health participate in first, large NIH-funded study of bone marrow transplant to cure sickle cell disease

(Medical College of Georgia at Augusta University) The Medical College of Georgia and Augusta University Health have joined the first large national clinical trial to determine if bone marrow transplantation should be part of the standard of care for patients with sickle cell disease.

Prescription drug distributor opens central Indiana facility

The state of Indiana says AmerisourceBergen plans to create more than 120 Indiana jobs in the coming years as part of its growth plans. The Chesterbrook, Pennsylvania-based company is investing more than $45 million to open the facility in a Whitestown industrial park.

Indiana University biologists create beetle with functional extra eye

(Indiana University) The creation of three-eyed beetles through a new technique developed at Indiana University will provides scientists a new way to investigate the genetic mechanisms behind the evolutionary emergence of new physical traits. The researchers recently reported their methods in the journal Current Biology.

Subset of stem cells identified as source for all cells in blood, immune systems

A specific subset of adult blood stem cells that is exclusively responsible for repopulating the entire blood and immune system after a transplant has now been identified by researchers. The discovery has the potential to revolutionize blood stem cell transplantation as well as the delivery and targeting of cell and gene therapies that use healthy versions of the self-renewing stem cells to replac...

NSF awards Indiana University $4 million to advance medical nanotechnology

(Indiana University) The Indiana University School of Informatics, Computing and Engineering has been awarded $4 million from the National Science Foundation to advance nanoscale devices to improve human health, including fighting cancer.


Quick Search
Advertisement
 

News Quicklinks